- Maintenance Therapy of Gastroesophageal Reflux Disease
-
Park SH
- KMID: 772781
- Korean J Gastroenterol.
- 2005 May;45(5):374-376.
No abstract availble -
- CITED
-
- Close
- SHARE
-
- Close
- Are Proton Pump Inhibitors Effective in Asthmatics with Gastroesophageal Reflux Disease?
-
Kim JH
- KMID: 1718423
- Korean J Gastroenterol.
- 2011 Oct;58(4):169-170.
- doi: 10.4166/kjg.2011.58.4.169
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Use of Proton Pump Inhibitors in Gastrointestinal Diseases
-
Rew JS
- KMID: 1113451
- Korean J Gastroenterol.
- 2006 Mar;47(3):181-190.
The development and introduction into clinical practice of proton pump inhibitors (PPIs) have influenced the management of acid-peptic disorders dramatically. PPIs inhibit the gastric hydrogen/potassium adenosine triphosphatase selectively and irreversibly... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Practice Patterns of Gastroenterologists for Initial and Maintenance Therapy in Gastroesophageal Reflux Disease: A Nationwide Online Survey in Korea
-
Chung SJ, Kim SG, Jung HC, Song IS, Kim JS
- KMID: 1775935
- Korean J Gastroenterol.
- 2009 Dec;54(6):364-370.
- doi: 10.4166/kjg.2009.54.6.364
BACKGROUND/AIMS: Gastroesophageal reflux disease (GERD) is a chronic condition and accompanied by frequent relapses. We aimed to evaluate the clinical practice patterns of gastroenterologists for initial and maintenance therapy of... -
- CITED
-
- Close
- SHARE
-
- Close
- 25 Years of Proton Pump Inhibitors: A Comprehensive Review
-
Strand DS, Kim D, Peura DA
- KMID: 2412152
- Gut Liver.
- 2017 Jan;11(1):27-37.
- doi: 10.5009/gnl15502
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Can Acid Pocket-targeting Alginate-antacid (Gaviscon Double Action) Relieve Upper Gastrointestinal Symptoms in Gastro-oesophageal Reflux Disease?
-
Kim SE, Park MI
- KMID: 2234043
- Korean J Gastroenterol.
- 2014 Jun;63(6):386-388.
- doi: 10.4166/kjg.2014.63.6.386
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of CYP2C19 Polymorphism and Helicobacter pylori Status on the Antisecretory Effect of Omeprazole in Gastroesophageal Reflux Disease
-
Sohn YH, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ
- KMID: 782759
- Korean J Gastroenterol.
- 2006 Sep;48(3):162-171.
BACKGROUND/AIMS: The acid suppressive effect of omeprazole (OMP) is influenced by the metabolic capacity of gastric acid suppression, which is dependent on CYP2C19 polymorphism. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Analysis of Recurrence Rate and Symptom Improvement in Gastro-esophageal Reflux Disease Patients
-
Jeong YJ, Lee DH, Choi TH, Hwang TJ, Lee BH, Nah JC, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N, Jung HC, Song IS
- KMID: 1718293
- Korean J Gastroenterol.
- 2010 Feb;55(2):100-108.
- doi: 10.4166/kjg.2010.55.2.100
BACKGROUND/AIMS: Gastro-esophageal reflux disease (GERD) is a chronic condition, with 50-80% of patients experiencing recurrence within one year following completion of initial treatment. The present study aimed to estimate recurrence... -
- CITED
-
- Close
- SHARE
-
- Close
